Skip to main content
Celina Kleer, MD, Pathology, Ann Arbor, MI

CelinaGKleerMD

Pathology Ann Arbor, MI

Anatomic Pathology, Clinical Pathology, Surgical Pathology

Professor of Pathology, and Harold A. Oberman Collegiate Professor of Pathology

Dr. Kleer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kleer's full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Ann Arbor, MI 48109
    Phone+1 734-936-4000

Education & Training

  • University of Michigan
    University of MichiganResidency, Pathology-Anatomic and Clinical, 1995 - 1999
  • Mayo Clinic College of Medicine and Science
    Mayo Clinic College of Medicine and ScienceInternship, Transitional Year, 1994 - 1995
  • University of Buenos Aires
    University of Buenos AiresClass of 1993

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1998 - 2027
  • American Board of Pathology Anatomic Pathology & Clinical Pathology

Publications & Presentations

PubMed

Press Mentions

  • When Tumors Collide: Analysis of Mixed-Type Breast Cancer Reveals Complexity
    When Tumors Collide: Analysis of Mixed-Type Breast Cancer Reveals ComplexityJuly 23rd, 2024
  • By Cannibalizing Nearby Stromal Stem Cells, Some Breast Cancer Cells Gain Invasion Advantage
    By Cannibalizing Nearby Stromal Stem Cells, Some Breast Cancer Cells Gain Invasion AdvantageJune 25th, 2019
  • Researchers Find Key Genetic Driver for Rare Type of Triple-Negative Breast Cancer
    Researchers Find Key Genetic Driver for Rare Type of Triple-Negative Breast CancerJanuary 8th, 2017
  • Join now to see all

Grant Support

  • Novel Functions of EZH2 in Triple Negative Breast Cancer: Translation into New Biomarker and Treatment StrategiesDepartment of Defense, Breast Cancer Research Program2015–2018
  • Role Of EZH2 In Breast Cancer ProgressionNational Cancer Institute2010–2012
  • Role Of CCN6 (WISP3) In The Progression And Metastasis Of Breast CancerNational Cancer Institute2008–2011
  • Role Of EZH2 In Breast CancerNational Cancer Institute2005–2009
  • Role Of LIBC In Inflammatory Breast Cancer PhenotypeNational Cancer Institute2003–2007

Professional Memberships

Other Languages

  • Spanish